An Indian manufacturing facility was cited for inadequate investigations of product quality complaints, poor root-cause analysis, and major failures in cleaning, maintenance, and validation of shared manufacturing equipment that posed cross-contamination risks
Discussion In this retrospective secondary analysis of routinely collected clinical data, we compared the efficacy and safety of semaglutide and dulaglutide in newly diagnosed, treatment-nave patients with type 2 diabetes and excess body weight
[DOI] [PubMed] [Google Scholar] 119
Some temporary lab results can change because of how your body adjusts to losing fat, not because of a higher risk to your heart
This can have effects on the acceptance of therapy or adherence in a patient with type 2 diabetes [20]
History of Tension Between Telehealth and Pharma Companies The conflict between Hims & Hers and Novo Nordisk did not emerge suddenly